Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-25T18:37:22.022Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuromodulation

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Extract

Dr. Janicak is professor of Psychiatry at Rush University in Chicago, Illinois, medical director of the Rush Psychiatric Clinical Research Center, and distinguished fellow at the American Psychiatric Association. He has been listed in Best Doctors of America since 1996, and Who's Who in America since 2002. In 2003, the Illinois chapter of the National Alliance for the Mentally III named Dr. Janicak “Psychiatrist of the Year.” With a strong interest in the assessment and treatment of mood and psychotic disorders, he has been a National Institute of Mental Health grant awardee as principal and co-investigator. Dr. Janicak is editor of the Psychopharm Review and has authored more than 250 publications in psychiatric literature, including Principles and Practice of Psychopharmacotherapy.

Type
In Session
Information
CNS Spectrums , Volume 13 , Issue 5 , May 2008 , pp. 370 - 378
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Rush, AJ, George, MS, Sackeim, HA, et al.Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicentered study. Biol Psychiatry. 2000;47:276–286.CrossRefGoogle Scholar
2.Sackeim, HA, Rush, AJ, George, MS, et al.Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713–728.CrossRefGoogle ScholarPubMed
3.Rush, AJ, Trivedi, MH, Wisniewski, SR, et al.Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917.CrossRefGoogle ScholarPubMed
4.Trivedi, MH, Fava, M, Wisniewski, SR, et al.Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243–1252.CrossRefGoogle ScholarPubMed
5.Janicak, PG, Dowd, SM, Martis, B, et al.Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depressive: preliminary results of a randomized trial. Biol Psychiatry. 2002;51:659–667.CrossRefGoogle ScholarPubMed
6.Janicak, PG, Dowd, SM, Rosa, M, Marcolin, MA. Transcranial magnetic stimulation versus electroconvulsive therapy for the treatment of more severe major depression. In: Marcolin, MA, Padberg, F, eds. Transcranial Brain Stimulation for Treatment of Psychiatric Disorders. (Advances in Biological Psychiatry). Basel, Switzerland: Karger. 2007;23:97–109.Google Scholar
7.O'Reardon, JP, Solvason, B, Janicak, PG, et al.Efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in the acute treatment of major depression: results of a multicenter randomized controlled trial. Biol Psychiatry. 2007;62:1208–1216.CrossRefGoogle Scholar
8.Janicak, PG, O'Reardon, JP, Sampson, SM, et al.Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure and reintroduction treatment. J Clin Psychiatry. In press.Google Scholar
9.Mayberg, HS, Lozano, AM, Voon, V, et al.Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–660.CrossRefGoogle ScholarPubMed